MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Substantia nigra"

  • 2022 International Congress

    STN-DBS Targeting SNr Modulates Sleep in Parkinson’s Disease: A Proof-of-Concept Study

    HL. Yu, LX. Guan, YN. Sui, F. Ba, LM. Li (Beijing, China)

    Objective: To explore how subthalamic deep brain stimulation (STN-DBS) targeting substantia nigra pars reticulata (SNr) can modulate sleep in Parkinson’s disease (PD) patients with electrophysiologic…
  • 2022 International Congress

    Genome-wide meta-analysis of Parkinson’s disease identifies a novel chromosomal 22 locus: findings from the COURAGE-PD consortium

    S. Grover, A. Kumar-Sreelatha, Z. Landoulsi, P. May, D. Bobbili, C. Domenighetti, C. Schulte, PE. Sugier, A. Elbaz, R. Krüger, T. Gasser, M. Sharma (Tuebingen, Germany)

    Objective: The present study aims to conduct a meta-analysis in a large, diverse cohort to discover novel Parkinson’s disease (PD) loci and replicate previously reported…
  • 2022 International Congress

    Gait abnormalities relate to increased extracellular water in the substantia nigra in Parkinson’s disease patients

    M. Bange, G. Gonzalez-Escamilla, N. Lang, A. Radetz, H. Ding, D. Herz, W. Schöllhorn, M. Muthuraman, S. Groppa (Mainz, Germany)

    Objective: The aim of this study was to investigate the role of substantia nigra microstructural integrity in parkinsonian gait impairments. Background: Gait impairments are common…
  • MDS Virtual Congress 2021

    Is Generalized and Segmental Dystonia Accompanied by Impairments of the Dopaminergic System?

    J. Ikezawa, F. Yokochi, R. Okiyama, S. Kumada, M. Tojima, T. Kamiyama, T. Hanakawa, H. Matsuda, F. Tanaka, Y. Nakata, E. Isozaki (Fuchu, Japan)

    Objective: To investigate functional dopaminergic impairments in dystonia, we compared patients with dystonia and Parkinson’s disease (PD) with normal controls using neuromelanin-sensitive magnetic resonance imaging…
  • MDS Virtual Congress 2021

    The evaluation of the swallow tail sign in patients with parkinsonism or gait disorders

    D. Kim, G. Tung, U. Akbar, J. Friedman (Providence, USA)

    Objective: The goal of the study is to evaluate the reliability of swallow tail sign which claimed to be specific for Parkinson's disease. Background: Swallow…
  • MDS Virtual Congress 2021

    Increased free-water in the substantia nigra in idiopathic REM sleep behaviour disorder

    L. Zhou, G. Li, Y. Zhang, B. Li, H. Wei, J. Liu (Shanghai, China)

    Objective: In this study, we tested the hypothesis that free water is elevated in the posterior substantia nigra of idiopathic rapid eye movement sleep behaviour…
  • MDS Virtual Congress 2021

    GBA Mutation Accumulates Higher Alpha-Synuclein in Alpha-Synucleinopathies

    T. Eid (London, United Kingdom)

    Objective: To investigate whether post-translational modifications of α-synuclein will give rise to species that differ between PD cases with N370S GBA mutation and WT-PD. Background:…
  • MDS Virtual Congress 2020

    Iron Imaging as a Diagnostic Tool for Parkinson’s Disease: A Systematic Review and Meta-Analysis

    N. Pyatigorskaya, C. Sanz Morere, R. Gaurav, E. Biondetti, R. Valabregue, M. Santin, L. Yahia-Cherif, S. Lehericy (Paris, France)

    Objective: We performed a systematic meta-analysis of SN iron imaging studies in PD to better understand the role of iron-sensitive MRI quantification to distinguish patients…
  • MDS Virtual Congress 2020

    Regional free-water differentially associated with glial activation, neuroinflammation, and neurodegeneration in de novo Parkinson’s disease

    D. Tosun, R. Ellis (San Francisco, CA, USA)

    Objective: Assess to what extent free-water(FW) as measured by diffusion-weighted MRI(dMRI) is a neuroimaging marker of glial activation, neuroinflammation, and neurodegeneration in de novo Parkinson’s disease(PD) patients from…
  • MDS Virtual Congress 2020

    Neurosonography of substantia nigra in patients with isolated essential tremor and in association with Parkinson’s disease of the family nature

    S. Munasipova, Z. Zalyalova (Kazan, Russian Federation)

    Objective: To identify differential clinical and neurosonographic criteria for ET and PD in patients with familial ET. Background: ET and PD are common disorders, especially…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley